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Reaction of N-bromosuccinimide with pig heart cytosolic aspartate aminotransferase ledto loss of the en- 
zymatic activity. Chemical analysis indicated the modification of two tryptophan residues. At a low ratio 
of N-bromosuccinimide to nzyme. oxidation of Trp 122 occurred without affecting the enzymatic activity. 
Increase in the ratio resulted in the oxidation of Trp 48 with a concomitant decrease in enzyme activity. 
The modified enzyme did not react with substrates and their analogs. Trp 48 is not within the active site 
but in the hinge region linking the large domain of the enzyme to the small domain that shows dynamic 
movement upon binding substrates. The present result suggests that oxidation of Trp 48 may impair the 
structural integrity of the interdomain interface. 
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1. INTRODUCTION 
Cytosolic aspartate aminotransferase @Asp-AT) 
(EC 2.6.1.1) from pig heart has 9 tryptophan 
residues per monomeric unit of the enzyme [l]. Of 
these, Trp 140 is situated in front of the lower part 
of the pyridine ring of the bound coenzyme, 
pyridoxal-P 121. The functional role of this active- 
site tryptophanyl residue is not known. However, 
its successful modification by nitrosodisulfonate 
led to a marked decrease in the enzyme activity of 
cAsp-AT [3]. All other tryptophan residues are 
located outside of the active site and their struc- 
tural and functions roles, if any, are not known. 
This paper describes the reaction of NBS with 
cAsp-AT leading to a marked decrease in enzymic 
activity with concomitant oxidation of Trp 48 that 
is not within the active site of the enzyme but is 
Abbreviaf~ons: NBS, ~-bromosuccinimide; pyridoxai- 
P, pyridoxal 5 ‘-phosphate; HPLC, high-performance 
liquid chromatography 
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located in a position important for the substrate- 
induced domain movement [2] of this enzyme. 
2. EXPERIMENTAL 
The a-subform of cAsp-AT was isolated from 
pig heart as in [4,5]. The purified enzyme showed 
a specific activity of 250 units/mg protein. The en- 
zyme concentration was calculated from the absor- 
bance of 12.5 at 280 nm for a 1% solution. NBS 
was obtained from Wako, Osaka. Other reagents 
were of the highest grade commercially available. 
A solution of 21.5 mM NBS in distilled water 
was prepared freshly prior to use. In typical ex- 
periments, appropriate voiumes of the NBS solu- 
tion were added to reaction mixtures (total volume 
1 .O ml) containing 1 mg (21.5 nmol as monomeric 
unit) of cAsp-AT in 0.1 M potassium phosphate 
buffer (pH 5.0) to give final NBS concentrations of 
0,1,2,3,4,5,6,7,8,10, and 15 molar excess over the 
monomeric unit of the enzyme. Incubation was 
performed for 10 min at 0°C. The reaction was ter- 
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minated by adding Na.&03 to a final concentra- 
tion of 1 mM. The resulting samples were deter- 
mined for enzyme activity and dialyzed overnight 
at 4°C against 50 mM Tris-HCI buffer (pH 7.5) 
containing 1 mM EDTA. 
The transamination activity was determined as 
described [S]. The rate of ~~-elimination reaction 
with 3-chloro-L-alanine was determined as in (61. 
pH titration of the enzyme spectra was performed 
on solutions containing 1 mg/ml of the native or 
NBS-modified enzyme in 0.1 M imidazole-acetate 
buffer at various pH values and prC values were ob- 
tained from the plots of reciprocals of absorbance 
at 430 nm vs the ratio of base to acid in buffers [7]. 
For amino acid analysis, enzyme and peptide 
samples were hydrolyzed at 110°C for 22-24 h in 
0.2 ml of 6 N HCI containing 0.05% 3-(2-amino- 
ethyl)indole, 0.5% thioglycolic acid and 0.25% 
phenol in evacuated and sealed tubes [8], 
Hydrolysates were analyzed for amino acid com- 
position in a KlOlAS automated amino acid 
analyzer (Kyowa Seimitsu, Tokyo). Methionine 
sulfoxide was determined by the procedure using 
treatment with cyanogen bromide [9]. 
Peptide mapping of tryptic digests of enzyme 
samples was performed as follows. Native and 
NBS-modified preparations of cAsp-AT were 
treated with NaBH4, carboxymethylated and 
digested with trypsin as in IlO]. The tryptic digests 
(- 1 mg) were taken in 200~1 of distilled water and 
chromatographed in a Hitachi model 638 HPLC 
system equipped with a Hitachi resin no. 5053 Cl8 
(4 x 250 mm). The elution was performed with two 
successive gradients using 0.1% ammonium 
acetate/acetonitrile (19 : 1) (solvent A) and 0.1% 
ammonium acetatelacetonitrile (4 : 6) (solvent B); 
the first gradient from 0 to 40% solvent B, fol- 
lowed by the second gradient from 40 to 100% sol- 
vent B. Elution of peptides was monitored at both 
210 and 280 nm. 
3. RESULTS AND DISCUSSION 
3.1. Inactivation of cAsp-A T by NBS 
The inactivation showed a critical dependency 
on the ratio of NBS to enzyme (fig. 1). Increase in 
the molar ratio up to 4 decreased the enzyme ac- 
tivity only by about 10%. Further increase in NBS 
resulted in progressive inactivation of the enzyme. 
Thus, the ratio of 4 appears to be a critical ratio at 
130 
which the inactivation starts. At a ratio of 8, the 
enzyme showed about 30% remaining activity for 
the transamination of natural dicarboxylic 
substrates as well as for the a&elimination reac- 
tion with 3-chloro-L-alanine. Further increase in 
the ratio led to the formation of aggregates of 
modified enzyme. The inactivation profile for 
either the apoenzyme or the pyridoxamine form of 
cAsp-AT did not differ from that for the pyridoxal 
form of the enzyme. Substrates uch as glutamate 
(40 mM), aspartate (40 mM) or 2-oxoglutarate (20 
mM) did not protect either form of the enzyme 
from inactivation by NBS. By contrast, glutarate 
(20 mM) or 2-methylaspartate (20 mM) increased 
the critical ratio of NBS to enzyme to 6 or 7, 
respectively, but the protection was not complete. 
These data are partly shown in fig.2. 
3.2. Identification of modified amino acid 
residues 
Modified preparations of cAsp-AT with 30% 
residual activity were hydrolyzed as described in 
section 2. Comparison with the native enzyme 
showed that two tryptophan residues per 
monomeric unit of the enzyme were oxidized by 
NBS and that other residues were not changed 
(table 1). The extent of inactivation as a function 
of the number of remaining tryptophan residues 
indicated that the enzyme activity was not ap- 
preciably affected during oxidation of the first 
Fig.1. Inactivation of cAsp-AT as a function of NBS to 
enzyme ratio. (0) Pyridoxal form, (0) pyridoxamine 
form, (0) apoenzyme. See text for details. 
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Fig.2. Effect of substrate or substrate analog on the 
inactivation of cAsp-AT by NBS. (- - -) Pyridoxal 
form alone (data from fig.l), (A) in the presence of 40 
mM L-glutamate, (A) in the presence of 20 mM 
2-methylaspartate. See text for details. 
tryptophan residue and the inactivation occurred 
progressively with the oxidation of an additional 
tryptophan residue (fig.3). Nonspecific oxidation 
of additional tryptophan residues appeared to oc- 
cur above the NBS to enzyme ratio of 6-7. A 
similar result was obtained with either the apoen- 
zyme or the pyridoxamine form of cAsp-AT. 
Table 1 
Comparison of amino acid residues between the native 
and NBS-modified preparation of cAsp-AT 
Amino acid residues Amounts found 
(mol/mol subunit) 
Native enzyme Modified enzyme 
Trp (9) 9.03 6.80 
LYS (19) 18.95 18.96 
His (8) 8.00 7.90 
Arg (26) 25.69 25.50 
Tyr (12) 12.10 11.90 
Phe (23) 22.98 22.94 
Methionine sulfoxide 0 0 
Cysteic acid 0 0 
Data for the sample with 30% remaining activity are 
shown. Numbers of residues derived from the sequence 
are shown in parentheses 
Fig.3. Extent of inactivation of cAsp-AT as a function 
of the number of remaining tryptophan residues. 
Samples obtained in the experiments described for fig. 1 
were analyzed for t~ptophan contents. 
To locate these two tryptophan residues in the 
known sequence of cAsp-AT [ 11, peptide-mapping 
patterns of tryptic digests were compared between 
the native enzyme, and modified enzyme samples 
with 93 and 49% remaining activity (fig.4). Peak 1 
was absent in the chromatogram of tryptic digests 
from the enzyme with 93% remaining activity 
(fig.4C). With the sample from the enzyme with 
49% remaining activity, peak 1 was also missing 
and peak 2 decreased in intensity by about 50% 
(fig.4D). This result indicates that the tryptophan 
residue of a peptide in peak 2 was closely related 
with the enzyme activity while that in peak 1 was 
not. Determination of amino acid compositions of 
these two peptides isolated from the native enzyme 
revealed that the peptide in peak 1 contained Trp 
122 and that in peak 2 contained Trp 48 (table 2). 
The peptide in peak 3 contained Trp 140. It is 
noted that this active-site residue [2] was not ox- 
idized by NBS (fig.4). 
by NBS 
A modified enzyme with 43 % remaining activity 
showed no sign of peptide bond cleavage on SDS- 
polyacrylamide gel electrophoresis. As described 
above, preparations which were modified to an ex- 
tent lower than 3~~~0 remaining activity showed 
a tendency to form aggregates. For this reason, 
spectral studies were performed on modified en- 
zyme samples with 40-48% remaining activity. 
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Fig.4. Comparison of HPLC tryptic peptide mapping 
between the native and NBS-modified preparations of 
cAsp-AT. (A) From the native enzyme; monitored at 280 
nm. (B) From the native enzyme; monitored at 220 nm. 
(C) From NBS-modified enzyme with 930/b remaining 
activity. (D) From NBS-modified enzyme with 49% 
remaining activity. (- - -) Gradient of acetonitrile. 
The pyridoxal form of cAsp-AT exhibits two ab- 
sorption bands at 362 and 430 nm which are at- 
tributed to the bound pyridoxal-P and known to 
act as a pH indicator. The protolytic pK value for 
the internal aldimine nitrogen in the native enzyme 
is 6.3 at an ionic strength of 0.1 [S]. The modified 
enzyme with 87% remaining activity showed a pK 
value of 6.3 while that with 48% remaining activity 
showed a higher value of 7.23. This seems to in- 
dicate that oxidation of Trp 48 might affect the 
ionic environment of the internal aldimine bond of 
the bound coenzyme. There was no sign of 
dissociation of pyridoxal-P by oxidation of Trp 48. 
Substrate analogs such as succinate, glutarate, 
ery~~~o-3-hydroxyaspartate and 2-methylaspartate 
are known to form complexes with the pyridoxal 
form of cAsp-AT, respectively exhibiting 
characteristic absorption spectra in the visible 
region 1111. When the pyridoxal form of cAsp-AT 
Table 2 
Amino acid composition of tryptophan-containing pep- 
tides from peaks 1 and 2 in chromatogram B in fig. 4 
Amino acids Peptide in peak 1 Peptide in peak 2 
Molar (Integer) Molar (Integer) 
ratio ratio 
S-CarboxymethyI- 
cysteine 
Aspartic acid 
Threonine 
Glutamic acid 
Proline 
Glycine 
Valine 
Leucine 
Tyrosine 
Lysine 
Arginine 
Tryptophan 
Assignmentb 
a - 
2.86 (3) 
0.81 (I) 
- 
0.93 (1) 
0.99 (1) 
- 
0.60 (1) 
WYNGTNNK TDDCQPWVLPVVR 
(residues I22- 129) (residues 42-54) 
1.14 (1) 
2.11 (1) 
0.89 (1) 
1.14 (1) 
2.15 (2) 
- 
3.13 (3) 
1.00 
- 
1.05 (1) 
0.67 (1) 
aNot detectable or less than 0.05 
bBased on the known amino acid sequence of cAsp-AT 
VI 
modified by NBS to various extents was spectrally 
monitored for the ability to form these complexes, 
it was found that the extent of formation of these 
complexes was quantitatively accounted for by the 
fraction of catalytically active species remaining in 
the modified preparations. Thus, oxidation of Trp 
48 seems to result in loss of the binding capacity 
for substrates and substrate analogs. 
Cryst~lographic studies of cAsp-AT [2] and the 
mitochondrial isoenzyme [12] indicated that the 
substrate specificity for dicarboxylates is deter- 
mined by two arginyl residues at position 292 and 
386 and that binding of dicarboxylic substrates in- 
duces a dynamic movement of the small domain 
(residues 14-47 and 350-412) toward the active-site 
pocket provided by the large domain (residues 
70-300). In cAsp-AT, Trp 48 is located in the 
region that connects the small domain to the large 
domain. The present result suggests that the con- 
version of the side chain of this tryptophan residue 
into oxyindole exerts a profound influence on the 
structural integrity of the interdomain region and 
thus impairs the proper movement of the small do- 
132 
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main which is necessary for productive binding of 
substrates and subsequent catalysis. 
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